Search

4D printing is the 3D printing of objects that change chemically or physically in response to an external stimulus over time. Photothermally responsive shape memory materials are attractive for their ability to undergo remote activation. While photothermal methods using gold nanorods (AuNRs) are used for shape recovery, 3D patterning of these materials into objects with complex geometries using degradable materials is not addressed. Here, the fabrication of 3D printed shape memory bioplastics with photo‐activated shape recovery is reported. Protein‐based nanocomposites based on bovine serum albumin (BSA), poly (ethylene glycol) diacrylate (PEGDA), and AuNRs are developed for vat photopolymerization. These 3D printed bioplastics are mechanically deformed under high loads, and the proteins served as mechano‐active elements that unfolded in an energy‐dissipating mechanism that prevented fracture of the thermoset. The bioplastic object maintained its metastable shape‐programmed state under ambient conditions. Subsequently, up to 99% shape recovery is achieved within 1 min of irradiation with near‐infrared (NIR) light. Mechanical characterization and small angle X‐ray scattering (SAXS) analysis suggest that the proteins mechanically unfold during the shape programming step and may refold during shape recovery. These composites are promising materials for the fabrication of biodegradable shape‐morphing devices for robotics and medicine. [ABSTRACT FROM AUTHOR]

Cancer-associated fibroblasts (CAFs) are abundant stromal cells in the tumor microenvironment that promote cancer progression and relapse. However, the heterogeneity and regulatory roles of CAFs underlying chemoresistance remain largely unclear. Here, we performed a single-cell analysis using high-dimensional flow cytometry analysis and identified a distinct senescence-like tetraspanin-8 (TSPAN8)+ myofibroblastic CAF (myCAF) subset, which is correlated with therapeutic resistance and poor survival in multiple cohorts of patients with breast cancer (BC). TSPAN8+ myCAFs potentiate the stemness of the surrounding BC cells through secretion of senescence-associated secretory phenotype (SASP)–related factors IL-6 and IL-8 to counteract chemotherapy. NAD-dependent protein deacetylase sirtuin 6 (SIRT6) reduction was responsible for the senescence-like phenotype and tumor-promoting role of TSPAN8+ myCAFs. Mechanistically, TSPAN8 promoted the phosphorylation of ubiquitin E3 ligase retinoblastoma binding protein 6 (RBBP6) at Ser772 by recruiting MAPK11, thereby inducing SIRT6 protein destruction. In turn, SIRT6 down-regulation up-regulated GLS1 and PYCR1, which caused TSPAN8+ myCAFs to secrete aspartate and proline, and therefore proved a nutritional niche to support BC outgrowth. By demonstrating that TSPAN8+SIRT6low myCAFs were tightly associated with unfavorable disease outcomes, we proposed that the combined regimen of anti-TSPAN8 antibody and SIRT6 activator MDL-800 is a promising approach to overcome chemoresistance. These findings highlight that senescence contributes to CAF heterogeneity and chemoresistance and suggest that targeting TSPAN8+ myCAFs is a promising approach to circumvent chemoresistance. Editor's summary: Cancer-associated fibroblasts (CAFs) are stromal cells that make up most of the tumor microenvironment (TME) and have been implicated in cancer progression and relapse, including in breast cancer (BC). Here, Fan et al. have identified a subset of TSPAN8+ myofibroblastic CAFs (myCAFs) that correlated to chemoresistance and poor survival in patients with BC. They found that these myCAFs potentiated stemness of BC cells through down-regulation of SIRT6. They next treated xenograft mice with the SIRT6 activator MDL-800 and anti-TSPAN8 antibody, which increased sensitivity to chemotherapy, suggesting a potential target that requires further investigation. —Dorothy Hallberg [ABSTRACT FROM AUTHOR]